OncoImmunology
Volume 7, 2018 - Issue 3
Open access
2,248
Views
19
CrossRef citations to date
0
Altmetric
Brief Report
Pro-inflammatory allogeneic DCs promote activation of bystander immune cells and thereby license antigen-specific T-cell responses
Grammatiki FotakiDepartment of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
, Chuan JinDepartment of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
, Mohanraj RamachandranDepartment of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
, Iliana Kyriaki KerzeliDepartment of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
, Alex Karlsson-ParraDepartment of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden;Immunicum AB
, Di YuDepartment of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, SwedenCorrespondence[email protected]
http://orcid.org/0000-0002-8636-0351
Magnus EssandDepartment of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
show all
Article: e1395126
|
Received 23 Aug 2017, Accepted 16 Oct 2017, Published online: 27 Nov 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.